79 related articles for article (PubMed ID: 38760429)
1. PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth.
Abe Y; Sano T; Otsuka N; Ogawa M; Tanaka N
Commun Biol; 2024 May; 7(1):593. PubMed ID: 38760429
[TBL] [Abstract][Full Text] [Related]
2. The Role of PRMT5 in Immuno-Oncology.
Abe Y; Sano T; Tanaka N
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980950
[TBL] [Abstract][Full Text] [Related]
3. STAT proteins in cancer: orchestration of metabolism.
Li YJ; Zhang C; Martincuks A; Herrmann A; Yu H
Nat Rev Cancer; 2023 Mar; 23(3):115-134. PubMed ID: 36596870
[TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry strategies targeting PRMT5 for cancer therapy.
Fu S; Zheng Q; Zhang D; Lin C; Ouyang L; Zhang J; Chen L
Eur J Med Chem; 2022 Dec; 244():114842. PubMed ID: 36274274
[TBL] [Abstract][Full Text] [Related]
5. The JAK-STAT pathway at 30: Much learned, much more to do.
Philips RL; Wang Y; Cheon H; Kanno Y; Gadina M; Sartorelli V; Horvath CM; Darnell JE; Stark GR; O'Shea JJ
Cell; 2022 Oct; 185(21):3857-3876. PubMed ID: 36240739
[TBL] [Abstract][Full Text] [Related]
6. JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
Erdogan F; Radu TB; Orlova A; Qadree AK; de Araujo ED; Israelian J; Valent P; Mustjoki SM; Herling M; Moriggl R; Gunning PT
J Cell Mol Med; 2022 Apr; 26(7):2049-2062. PubMed ID: 35229974
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions.
Tesoriere A; Dinarello A; Argenton F
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440160
[TBL] [Abstract][Full Text] [Related]
8. The role of understudied post-translational modifications for the behavior and function of Signal Transducer and Activator of Transcription 3.
Diallo M; Herrera F
FEBS J; 2022 Oct; 289(20):6235-6255. PubMed ID: 34235865
[TBL] [Abstract][Full Text] [Related]
9. PRMT5 Enables Robust STAT3 Activation via Arginine Symmetric Dimethylation of SMAD7.
Cai C; Gu S; Yu Y; Zhu Y; Zhang H; Yuan B; Shen L; Yang B; Feng XH
Adv Sci (Weinh); 2021 May; 8(10):2003047. PubMed ID: 34026434
[TBL] [Abstract][Full Text] [Related]
10. Protein arginine methylation: from enigmatic functions to therapeutic targeting.
Wu Q; Schapira M; Arrowsmith CH; Barsyte-Lovejoy D
Nat Rev Drug Discov; 2021 Jul; 20(7):509-530. PubMed ID: 33742187
[TBL] [Abstract][Full Text] [Related]
11. MYD88 signals induce tumour-initiating cell generation through the NF-κB-HIF-1α activation cascade.
Tanimura A; Nakazato A; Tanaka N
Sci Rep; 2021 Feb; 11(1):3991. PubMed ID: 33597599
[TBL] [Abstract][Full Text] [Related]
12. STAT3 and STAT5 Activation in Solid Cancers.
Igelmann S; Neubauer HA; Ferbeyre G
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31557897
[TBL] [Abstract][Full Text] [Related]
13. MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex.
Abe Y; Suzuki Y; Kawamura K; Tanaka N
Commun Biol; 2019; 2():23. PubMed ID: 30675521
[TBL] [Abstract][Full Text] [Related]
14. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer.
Shailesh H; Zakaria ZZ; Baiocchi R; Sif S
Oncotarget; 2018 Nov; 9(94):36705-36718. PubMed ID: 30613353
[TBL] [Abstract][Full Text] [Related]
15. Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map.
Huynh J; Chand A; Gough D; Ernst M
Nat Rev Cancer; 2019 Feb; 19(2):82-96. PubMed ID: 30578415
[TBL] [Abstract][Full Text] [Related]
16. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
Jones SA; Jenkins BJ
Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
[TBL] [Abstract][Full Text] [Related]
17. Stem cell fate in cancer growth, progression and therapy resistance.
Lytle NK; Barber AG; Reya T
Nat Rev Cancer; 2018 Nov; 18(11):669-680. PubMed ID: 30228301
[TBL] [Abstract][Full Text] [Related]
18. Sphere-Formation Assay: Three-Dimensional
Bahmad HF; Cheaito K; Chalhoub RM; Hadadeh O; Monzer A; Ballout F; El-Hajj A; Mukherji D; Liu YN; Daoud G; Abou-Kheir W
Front Oncol; 2018; 8():347. PubMed ID: 30211124
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
